East Carolina University Hematology and Medical Oncology

Topics

• Cancer Immunotherapy and Biomarkers 59
• Acute Myeloid Leukemia Research 42
• CAR-T cell therapy research 40
• Hematopoietic Stem Cell Transplantation 36
• Hemoglobinopathies and Related Disorders 25
• Multiple Myeloma Research and Treatments 25
• Complementary and Alternative Medicine Studies 21
• Lung Cancer Treatments and Mutations 21
• Cancer survivorship and care 14
• Liver Diseases and Immunity 14
• Chronic Lymphocytic Leukemia Research 13
• Lymphoma Diagnosis and Treatment 13

Most cited

1. Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 1,255 citations · Aparna Hegde

2. Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.

   The New England journal of medicine · 2023 · 739 citations · Aparna Hegde

3. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 813 citations · Aparna Hegde

4. NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 469 citations · Aparna Hegde

5. Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 415 citations · Aparna Hegde

6. Integrative oncology: Addressing the global challenges of cancer prevention and treatment.

   CA: a cancer journal for clinicians · 2022 · 320 citations · Gabriel Lopez